newsfilter
← Latest News
GlobeNewswire·

OpGen Subsidiary Curetis Meets Several Key Milestones in FIND Collaboration Project

ROCKVILLE, Md., Jan. 17, 2023 (GLOBE NEWSWIRE) -- OpGen, Inc. (NASDAQ:OPGN, "OpGen" or "the Company")), a precision medicine company harnessing the power of molecular diagnostics and bioinformatics to help combat